This training on FDA compliance will provide the attendees with an understanding of FDA expectations regarding end-of-phase 2A meeting guidance. Attendees will learn the best practices to comply with the intent of the guidance and to achieve a higher quality outcome from the meeting.
Driving Quality and Compliance in Drug Development Through the FDA End-of-Phase 2A Meeting
23 January 2014, Palo Alto, United States
Introduction
Venue
Online Event
Online Event, 2600 E. Bayshore Road, Palo Alto, 94303, United States
Organised by
ComplianceOnlinr
Contact information
Related events
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
7th International Conference on Nanomaterials Science and Mechanical Engineering
8 July 2025 08:00 - 11 July 2025 18:00, Aveiro, Portugal
21st RSC Nucleic Acids Forum – 2025
11 July 2025 10:00-18:00, London, United Kingdom
Nano Exploration of MXenes 2025 - #NEMX25
3 - 7 March 2025, Seville, Spain
Search
Advertisement
Spotlight
Explore
© Royal Society of Chemistry 2024
Registered charity number: 207890
Registered charity number: 207890
